Jeff Seidl

Jeff Seidl has a background in Human Developmental and Regenerative Biology from Harvard University. Starting as an Undergrad Researcher at Massachusetts General Hospital, Jeff later became a Cofounder at Swellbox, eventually being acquired by Datavant where Jeff now holds the position of Partnerships Lead focusing on patient requests. Jeff also had experience as an Associate at Flat World Partners. Notably, Jeff has been published in a paper titled "tiRNA signaling via stress-regulated vesicle transfer in the hematopoietic niche."